Trials / Completed
CompletedNCT03158506
Human Mass Balance Study of HMS5552 in Healthy Subjects
An Open-Label, Single Center Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of 50 mg (90 uCi) [14C]-HMS5552 in Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Hua Medicine Limited · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, single center, 1-period study in healthy adult male subjects to assess absorption, metabolism, and excretion of HMS5552 after a single oral administration of 50 mg (90 μCi) of \[14C\]-HMS5552.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HMS5552 | \[14C\]-labelled HMS5552 |
Timeline
- Start date
- 2017-03-29
- Primary completion
- 2017-04-06
- Completion
- 2017-04-06
- First posted
- 2017-05-18
- Last updated
- 2018-12-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03158506. Inclusion in this directory is not an endorsement.